Cancer screening of long-term cancer survivors.
Cancer screening of long-term cancer survivors.
复制标题
DOI:
10.3122/jabfm.2012.04.110118
复制
发表时间:
2012-07
期刊:
影响因子:
--
通讯作者:
Smith MA
中科院分区:
文献类型:
--
作者:
Schumacher JR;Witt WP;Palta M;Loconte NK;Heidrich SM;Trentham-Dietz A;Pandhi N;Smith MA
Although 64% of cancer survivors are expected to live at least five years beyond diagnosis, the receipt of cancer screening by this population is unclear. The study objective is to assess the relation between a cancer diagnosis and future cancer screening, exploring provider, patient, and cancer-specific factors that explain observed relationships. The Wisconsin Longitudinal Study (WLS) and Wisconsin Tumor Registry were used to identify two participant groups: 415 diagnosed with non-metastatic cancer between 1992-1993 (pre-cancer) and 2003-2004 (post-cancer) and 4,680 no-cancer controls. Adjusted average predicted probabilities of cancer screening were estimated with models that first did not include and then included, provider (provider relationship length), participant (depressive symptoms (CES-D)) and cancer-specific (time since diagnosis) factors. Participants with a history of the cancer associated with a given screening test were then excluded to assess whether relationships are explained by screening for recurrence versus second cancers. Female cancer survivors were more likely than no-cancer controls to undergo pelvic/pap (70%, 95% confidence interval (CI)=63-76% and 61%,CI=59-63%) and mammography screening (86%,CI=78-90% and 76%,CI=74-77%), though male cancer survivors were not more likely to receive prostate exams (76%,CI=70-82% and 69%,CI=67-71%). After excluding people with a history of the cancer being screened for, there were few significant differences in cancer screening between short or long-term survivors (>5 years) and no-cancer controls. Relationships were not sensitive to adjustment for provider or participant factors. The significant positive differences in cancer screening between people with and without cancer can be explained by screening for recurrence. Long-term cancer survivors are not more likely to receive follow-up screening for second cancers. This information should be used by providers to ensure patients receive recommended follow-up preventive care.
登录
查看更多内容
影响因子:
2.7
作者:
Green, CA;Pope, CR
通讯作者:
Pope, CR
影响因子:
45.3
作者:
Mao, Jun J.;Bowman, Marjorie A.;Armstrong, Katrina
通讯作者:
Armstrong, Katrina
DOI:
10.1007/s11764-008-0058-x
发表时间:
2008-09-01
期刊:
Journal of cancer survivorship : research and practice
影响因子:
--
作者:
Bloom, Joan R;Stewart, Susan L;Banks, Priscilla J
通讯作者:
Banks, Priscilla J
影响因子:
45.3
作者:
Bellizzi, KM;Rowland, JH;McNeel, T
通讯作者:
McNeel, T
影响因子:
5
作者:
ANDERSEN, RM
通讯作者:
ANDERSEN, RM